Eyenovia (EYEN) News Today → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free EYEN Stock Alerts $0.75 -0.03 (-3.82%) (As of 10:17 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | investorplace.comPeek Behind the Curtain: 7 Penny Stocks With Heavy Insider BuyingMay 21, 2024 | markets.businessinsider.comAll You Need to Know About Eyenovia Rating Upgrade to BuyMay 17, 2024 | msn.comEyenovia, Inc. (NASDAQ:EYEN) Q1 2024 Earnings Call TranscriptMay 16, 2024 | finance.yahoo.comEyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...May 16, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Eyenovia (NASDAQ:EYEN)HC Wainwright restated a "buy" rating and issued a $12.00 price target on shares of Eyenovia in a report on Thursday.May 15, 2024 | globenewswire.comEyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and ClobetasolMay 14, 2024 | globenewswire.comEyenovia to Report First Quarter 2024 Results on Wednesday, May 15thMay 12, 2024 | za.investing.comEarnings call: NovaBay reports record Avenova sales, eyes dry eye marketMay 4, 2024 | cnn.comEyenovia, Inc.April 26, 2024 | finanznachrichten.deEyenovia, Inc.: Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic SuspensionApril 25, 2024 | globenewswire.comEyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic SuspensionApril 17, 2024 | msn.comEyenovia (EYEN) Price Target Decreased by 24.29% to 7.21April 10, 2024 | investing.comEyenovia explores strategic alternatives amid new product developmentsApril 8, 2024 | marketwatch.comEyenovia Shares Fall More Than 14% After Company Says It Is Exploring SaleApril 8, 2024 | marketwatch.comEyenovia Explores Options, Including Potential SaleApril 8, 2024 | globenewswire.comEyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial OpportunitiesApril 5, 2024 | reuters.comEyenovia IncApril 4, 2024 | msn.comLenz Therapeutics’ Eye Drop Helps Improve Vision in Late-Stage StudyApril 3, 2024 | globenewswire.comEyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare MeetingsMarch 30, 2024 | insidertrades.comStuart M. Grant Acquires 100,000 Shares of Eyenovia, Inc. (NASDAQ:EYEN) StockMarch 22, 2024 | marketbeat.comBrokers Set Expectations for Eyenovia, Inc.'s Q2 2024 Earnings (NASDAQ:EYEN)Eyenovia, Inc. (NASDAQ:EYEN - Free Report) - Research analysts at HC Wainwright issued their Q2 2024 earnings per share estimates for shares of Eyenovia in a report released on Tuesday, March 19th. HC Wainwright analyst M. Caufield expects that the company will earn ($0.19) per share for the quarMarch 21, 2024 | insidertrades.comEyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Acquires $61,500.00 in StockMarch 20, 2024 | marketbeat.comInsider Buying: Eyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases 50,000 Shares of StockEyenovia, Inc. (NASDAQ:EYEN - Get Free Report) major shareholder Stuart M. Grant bought 50,000 shares of the stock in a transaction dated Tuesday, March 19th. The stock was bought at an average cost of $1.23 per share, for a total transaction of $61,500.00. Following the acquisition, the insider now directly owns 5,330,715 shares of the company's stock, valued at approximately $6,556,779.45. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.March 20, 2024 | seekingalpha.comEyenovia, Inc. (EYEN) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | marketbeat.comEyenovia, Inc. (NASDAQ:EYEN) Short Interest UpdateEyenovia, Inc. (NASDAQ:EYEN - Get Free Report) saw a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 2,890,000 shares, an increase of 8.2% from the February 14th total of 2,670,000 shares. Based on an average trading volume of 715,400 shares, the short-interest ratio is currently 4.0 days.March 19, 2024 | finanznachrichten.deEyenovia, Inc.: Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | markets.businessinsider.comEyenovia’s Strategic Commercial Synergy and Growth Potential Reinforce Buy RatingMarch 19, 2024 | finance.yahoo.comEyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | marketbeat.comEyenovia (NASDAQ:EYEN) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPSEyenovia (NASDAQ:EYEN - Get Free Report) released its earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, topping analysts' consensus estimates of ($0.18) by $0.01. During the same quarter in the previous year, the business earned ($0.17) earnings per share.March 19, 2024 | marketbeat.comEyenovia (NASDAQ:EYEN) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $12.00 price target on shares of Eyenovia in a report on Tuesday.March 19, 2024 | finance.yahoo.comQ4 2023 Eyenovia Inc Earnings CallMarch 18, 2024 | benzinga.comRecap: Eyenovia Q4 EarningsMarch 18, 2024 | investorplace.comEYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | markets.businessinsider.comEyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 18, 2024 | globenewswire.comEyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 17, 2024 | msn.comEyenovia Q4 2023 Earnings PreviewMarch 17, 2024 | marketbeat.comEyenovia (EYEN) Scheduled to Post Quarterly Earnings on MondayEyenovia (NASDAQ:EYEN) will be releasing earnings after the market closes on Monday, March 18, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=573125)March 13, 2024 | globenewswire.comNovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare ProfessionalsMarch 12, 2024 | marketbeat.comEyenovia (EYEN) to Release Quarterly Earnings on MondayEyenovia (NASDAQ:EYEN) will be releasing earnings after the market closes on Monday, March 18, Zacks reports.March 12, 2024 | insidertrades.comInsider Buying: Eyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases 10,717 Shares of StockMarch 11, 2024 | marketbeat.comEyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases $16,932.86 in StockEyenovia, Inc. (NASDAQ:EYEN - Get Free Report) major shareholder Stuart M. Grant acquired 10,717 shares of the business's stock in a transaction dated Friday, March 8th. The stock was purchased at an average cost of $1.58 per share, for a total transaction of $16,932.86. Following the transaction, the insider now owns 5,280,715 shares in the company, valued at $8,343,529.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.March 11, 2024 | markets.businessinsider.comEyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18thMarch 11, 2024 | globenewswire.comEyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18thMarch 7, 2024 | marketbeat.comFY2025 Earnings Forecast for Eyenovia, Inc. Issued By William Blair (NASDAQ:EYEN)Eyenovia, Inc. (NASDAQ:EYEN - Free Report) - William Blair decreased their FY2025 EPS estimates for shares of Eyenovia in a report issued on Tuesday, March 5th. William Blair analyst T. Lugo now anticipates that the company will earn ($1.55) per share for the year, down from their previous forecaMarch 6, 2024 | markets.businessinsider.comEyenovia, Formosa Gets FDA Approval For Clobetasol Propionate Ophthalmic Eye DropsMarch 6, 2024 | markets.businessinsider.comEyenovia’s Strategic Expansion: Dual Product Offering Enhances Market PositionMarch 6, 2024 | msn.comEyenovia falls despite FDA nod for pain therapyMarch 6, 2024 | finance.yahoo.comBeyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, InflammationMarch 5, 2024 | globenewswire.comEyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular SurgeryMarch 4, 2024 | reuters.comUS FDA approves Eyenovia's eye drug, Formosa Pharma says Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Why June 30 Will Be the Tipping Point for AI (Ad)AI is already replacing workers in warehouses. It’s spreading like lightning in the software, legal and engineering industries… It’s now estimated at least 300 million jobs worldwide are in AI’s crosshairs. Click here for details. EYEN Media Mentions By Week EYEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.000.73▲Average Medical News Sentiment EYEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼02▲EYEN Articles Average Week Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GTHX News Today RIGL News Today GALT News Today ATOS News Today SGMT News Today RZLT News Today ALIM News Today PRQR News Today MCRB News Today CNTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does ...Porter & Company | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored